Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.

Seymour JF, Döhner H, Butrym A, Wierzbowska A, Selleslag D, Jang JH, Kumar R, Cavenagh J, Schuh AC, Candoni A, Récher C, Sandhu I, Del Castillo TB, Al-Ali HK, Falantes J, Stone RM, Minden MD, Weaver J, Songer S, Beach CL, Dombret H

Open source

DOI
10.1186/s12885-017-3803-6
Published
2017 Dec 14
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-017-3803-6,
  title = {Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.},
  author = {Seymour JF and Döhner H and Butrym A and Wierzbowska A and Selleslag D and Jang JH and Kumar R and Cavenagh J and Schuh AC and Candoni A and Récher C and Sandhu I and Del Castillo TB and Al-Ali HK and Falantes J and Stone RM and Minden MD and Weaver J and Songer S and Beach CL and Dombret H},
  year = {2017},
  journal = {BMC cancer},
  doi = {10.1186/s12885-017-3803-6},
  url = {https://doi.org/10.1186/s12885-017-3803-6}
}

RIS

TY  - JOUR
TI  - Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
AU  - Seymour JF
AU  - Döhner H
AU  - Butrym A
AU  - Wierzbowska A
AU  - Selleslag D
AU  - Jang JH
AU  - Kumar R
AU  - Cavenagh J
AU  - Schuh AC
AU  - Candoni A
AU  - Récher C
AU  - Sandhu I
AU  - Del Castillo TB
AU  - Al-Ali HK
AU  - Falantes J
AU  - Stone RM
AU  - Minden MD
AU  - Weaver J
AU  - Songer S
AU  - Beach CL
AU  - Dombret H
PY  - 2017
JO  - BMC cancer
DO  - 10.1186/s12885-017-3803-6
UR  - https://doi.org/10.1186/s12885-017-3803-6
ER  - 

APA

JF, S., H, D., A, B., A, W., D, S., JH, J., R, K., J, C., AC, S., A, C., C, R., I, S., TB, D. C., HK, A., J, F., RM, S., MD, M., J, W., S, S., CL, B., & H, D. (2017). Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.. BMC cancer. https://doi.org/10.1186/s12885-017-3803-6

Source records